OVERLAND PARK, Kan.--(BUSINESS WIRE)--Vince & Associates Clinical Research, a premier provider of early phase clinical research services, is pleased to announce that Dr. Brad Vince, the company’s CEO, founder and medical director, has been named as one of the 100 most inspiring people in the life sciences industry by PharmaVOICE Magazine.
According to PharmaVOICE, the PharmaVOICE 100 is “a means to celebrate the men and women through the life sciences industry who provide inspiration to their peers, colleagues, and companies through their innovative and motivation approaches to addressing the industry’s myriad challenges.” We are proud that Dr. Vince has been counted among these honored few.
A clinical research industry veteran for more than 15 years, Dr. Vince was recognized for his positive influence in the industry. His most notable contributions include guiding research and development efforts in early phase clinical trials, making innovative strides in the recruitment and retention of volunteers as well as the operational conduct of complex clinical trials.
“I am truly honored to be named as one of the 100 most inspiring people in the life science industry. This prestigious recognition by PharmaVOICE has only been possible because of the dedication of our research staff, the confidence of our clients and, most importantly, our study volunteers who choose to participate in clinical trials,” said Dr. Vince.
About Vince & Associates Clinical Research
Vince & Associates Clinical Research has provided clinical research services to the biopharmaceutical industry for 15 years. The research professionals at Vince & Associates are proud to be recognized in the industry as a “Center of Research Excellence.”
Vince & Associates currently operates a state-of-the-art, multimillion-dollar, 100-bed clinical pharmacology unit that combines the ultimate in subject safety and luxury. This early development unit has the upscale atmosphere necessary for the recruitment and retention of study volunteers in both short- and long-term clinical trials. From the safety and security of the controlled access unit to the added features of a movie theater and game rooms, no detail has been overlooked.
Altasciences is the parent company of wholly owned subsidiaries Vince & Associates Clinical Research (Kansas, USA), Algorithme Pharma (Quebec, Canada) and Algorithme Pharma USA (North Dakota, USA). All three organizations provide comprehensive early stage clinical services in Phase I/IIa, including the necessary support services in this critical stage of drug development.
Additional background materials pertaining to Vince & Associates Clinical Research are located on the corporate website at www.vinceandassociates.com.